Jeffrey L. Brown

3.6k total citations · 1 hit paper
69 papers, 2.9k citations indexed

About

Jeffrey L. Brown is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jeffrey L. Brown has authored 69 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jeffrey L. Brown's work include Fungal and yeast genetics research (11 papers), Medical Malpractice and Liability Issues (5 papers) and Neuroblastoma Research and Treatments (4 papers). Jeffrey L. Brown is often cited by papers focused on Fungal and yeast genetics research (11 papers), Medical Malpractice and Liability Issues (5 papers) and Neuroblastoma Research and Treatments (4 papers). Jeffrey L. Brown collaborates with scholars based in United States, Canada and United Kingdom. Jeffrey L. Brown's co-authors include Howard Bussey, Richard C. Stewart, John Chant, S M North, Alvise Berti, Erika Zonari, Anna Ranghetti, Letterio S. Politi, Bernhard Gentner and Michele De Palma and has published in prestigious journals such as JAMA, Genes & Development and The Journal of Cell Biology.

In The Last Decade

Jeffrey L. Brown

64 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells

2011 489 citations Jeffrey L. Brown et al. profile →

Peers

Jeffrey L. Brown

MB

ONCOL

PS

CB

CR

Juan Du China

Hugh Mitchell United States

Régen Drouin Canada

Morris F. Manolson Canada

Min Fang United States

Qing Chen China

Xiaonan Wang China

Jianhua Liu China

Weikuan Gu United States

Juan Du China

Jeffrey L. Brown

1.8k ×1.0

MB

317 ×0.6

ONCOL

822 ×1.8

PS

237 ×0.6

CB

352 ×1.1

CR

Citations per year, relative to Jeffrey L. Brown Jeffrey L. Brown (= 1×) peers Juan Du

Countries citing papers authored by Jeffrey L. Brown

Since Specialization

Citations

This map shows the geographic impact of Jeffrey L. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey L. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey L. Brown more than expected).

Fields of papers citing papers by Jeffrey L. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey L. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey L. Brown. The network helps show where Jeffrey L. Brown may publish in the future.

Co-authorship network of co-authors of Jeffrey L. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey L. Brown. A scholar is included among the top collaborators of Jeffrey L. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey L. Brown. Jeffrey L. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Yu, Ziyang, Suqin He, Hitisha Patel, et al.. (2017). Selective Androgen Receptor Modulator RAD140 Inhibits the Growth of Androgen/Estrogen Receptor–Positive Breast Cancer Models with a Distinct Mechanism of Action. Clinical Cancer Research. 23(24). 7608–7620. 23 indexed citations

2.

Bihani, Teeru, Hitisha Patel, Heike Arlt, et al.. (2017). Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER+ Breast Cancer Patient-derived Xenograft Models. Clinical Cancer Research. 23(16). 4793–4804. 119 indexed citations

3.

Paul, Stephan & Jeffrey L. Brown. (2013). Beware of potential liability risks when sharing patient responsibilities. AAP News. 34(1). 16–16. 1 indexed citations

4.

Brown, Jeffrey L.. (2013). Medical-legal risks associated with circumcision of newborn males: need for revised consent. AAP News. 34(4). 1–1. 5 indexed citations

5.

Hwang, Rosa F., Todd T. Moore, Maureen M. Hattersley, et al.. (2012). Inhibition of the Hedgehog Pathway Targets the Tumor-Associated Stroma in Pancreatic Cancer. Molecular Cancer Research. 10(9). 1147–1157. 82 indexed citations

6.

Brown, Jeffrey L.. (2012). Be aware of possible liability risks when using electronic health records. AAP News. 33(6). 16–16. 1 indexed citations

7.

Brown, Jeffrey L.. (2012). Physicians have ethical, legal obligation to report child abuse. AAP News. 33(3). 20–20. 2 indexed citations

8.

Ivanov, Sergey V., Brandee Brown, Yan Guo, et al.. (2012). TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior. Oncogene. 32(32). 3698–3710. 62 indexed citations

9.

Parsels, Leslie A., Yushen Qian, Daria M. Tanska, et al.. (2011). Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition. Clinical Cancer Research. 17(11). 3706–3715. 67 indexed citations

10.

Brown, Jeffrey L., Zhe Cao, Maria Pinzon-Ortiz, et al.. (2010). A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models. Molecular Cancer Therapeutics. 9(1). 145–156. 113 indexed citations

11.

Thress, Kenneth S., Terry Macintyre, Haiyun Wang, et al.. (2009). Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway. Molecular Cancer Therapeutics. 8(7). 1818–1827. 51 indexed citations

12.

Brown, Jeffrey L.. (2008). Telephone care requires use of language that paints clear picture for parent, doctor. AAP News. 29(3). 22–22. 1 indexed citations

13.

Brown, Jeffrey L.. (2006). Managing legal risks of pediatric telephone care. AAP News. 27(10). 17–17. 6 indexed citations

14.

Brown, Jeffrey L., et al.. (2006). Ethical Clinical Practice and Sport Psychology: When Two Worlds Collide. Ethics & Behavior. 16(1). 15–23. 13 indexed citations

15.

Roth, Jeffrey, Vivian Gahtan, Jeffrey L. Brown, et al.. (1998). Thrombospondin-1 Is Elevated with both Intimal Hyperplasia and Hypercholesterolemia. Journal of Surgical Research. 74(1). 11–16. 81 indexed citations

16.

Brown, Jeffrey L., et al.. (1996). Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway. Current Biology. 6(5). 598–605. 221 indexed citations

17.

Jiang, Bo, et al.. (1994). A new family of yeast genes implicated in ergosterol synthesis is related to the human oxysterol binding protein. Yeast. 10(3). 341–353. 90 indexed citations

18.

Brown, Jeffrey L., Howard Bussey, & Richard C. Stewart. (1994). Yeast Skn7p functions in a eukaryotic two-component regulatory pathway.. The EMBO Journal. 13(21). 5186–5194. 137 indexed citations

19.

Brown, Jeffrey L., et al.. (1993). A mutational analysis of killer toxin resistance in Saccharomyces cerevisiae identifies new genes involved in cell wall (1-->6)-beta-glucan synthesis.. Genetics. 133(4). 837–849. 92 indexed citations

20.

Brown, Jeffrey L.. (1969). A Supplement to “A High Status Burial from Grasshopper Ruin, Arizona”. KIVA. 35(2). 87–90. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact